LFMD
Price
$2.19Alerts
Change
+$0.54 (+32.73%)
Updated
Nov 13 closing price
Capitalization
114.37M
121 days until earnings call
Intraday BUY SELL Signals
PETS
Price
$0.94Alerts
Change
-$0.05 (-5.05%)
Updated
Nov 13 closing price
Capitalization
26.45M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFMD vs PETS

LFMD vs PETS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LFMD vs. PETS commentary
Nov 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFMD is a Buy and PETS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LFMD with price predictions
Nov 13, 2026

LFMD in +9.43% Uptrend, growing for three consecutive days on October 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LFMD advanced for three days, in 250 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LFMD's RSI Oscillator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

LFMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFMD as a result. In 70 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The Moving Average Convergence Divergence Histogram (MACD) for LFMD turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 36 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for LFMD entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.356) is normal, around the industry mean (4.523). LFMD has a moderately low P/E Ratio (-59.250) as compared to the industry average of (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.788) is also within normal values, averaging (6.105).

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. LFMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
a Summary for PETS with price predictions
Nov 13, 2026

PETS's RSI Oscillator is staying in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where PETS advanced for three days, in 144 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

PETS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PETS as a result. In 91 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for PETS turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 41 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for PETS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.151) is normal, around the industry mean (1.378). P/E Ratio (-0.891) is within average values for comparable stocks, (-2.174). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (0.984) as compared to the industry average of (0.246). P/S Ratio (0.200) is also within normal values, averaging (2.504).

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

FUNDAMENTALS RATINGS
LFMD vs PETS: Fundamental Ratings
LFMD
PETS
OUTLOOK RATING
1..100
215
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9187
P/E GROWTH RATING
1..100
1012
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PETS's Valuation (4) in the Drugstore Chains industry is in the same range as LFMD (9) in the null industry. This means that PETS’s stock grew similarly to LFMD’s over the last 12 months.

PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as LFMD (100) in the null industry. This means that PETS’s stock grew similarly to LFMD’s over the last 12 months.

PETS's SMR Rating (98) in the Drugstore Chains industry is in the same range as LFMD (98) in the null industry. This means that PETS’s stock grew similarly to LFMD’s over the last 12 months.

PETS's Price Growth Rating (87) in the Drugstore Chains industry is in the same range as LFMD (91) in the null industry. This means that PETS’s stock grew similarly to LFMD’s over the last 12 months.

LFMD's P/E Growth Rating (10) in the null industry is in the same range as PETS (12) in the Drugstore Chains industry. This means that LFMD’s stock grew similarly to PETS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFMDPETS
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 13 days ago
64%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 14, 2026
Stock price -- (LFMD: $2.19 vs. PETS: $0.94)
Brand notoriety: LFMD and PETS are both not notable
LFMD represents the Services to the Health Industry, while PETS is part of the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: LFMD: 701% vs. PETS: 260%
Market capitalization -- LFMD: $114.37M vs. PETS: $26.45M
LFMD [@Services to the Health Industry] is valued at $114.37M. PETS’s [@Drugstore Chains] market capitalization is $26.45M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The market cap for tickers in the [@Drugstore Chains] industry ranges from $36.55K to $14.27B. The average market capitalization across the [@Services to the Health Industry] industry is $3.31B. The average market capitalization across the [@Drugstore Chains] industry is $82.05M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFMD’s FA Score shows that 2 FA rating(s) are green while PETS’s FA Score has 2 green FA rating(s).

  • LFMD’s FA Score: 2 green, 3 red.
  • PETS’s FA Score: 2 green, 3 red.
According to our system of comparison, both LFMD and PETS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFMD’s TA Score shows that 4 TA indicator(s) are bullish while PETS’s TA Score has 4 bullish TA indicator(s).

  • LFMD’s TA Score: 4 bullish, 4 bearish.
  • PETS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both LFMD and PETS are a good buy in the short-term.

Price Growth

LFMD (@Services to the Health Industry) experienced а -7.38% price change this week, while PETS (@Drugstore Chains) price change was -22.93% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.19%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +22.53%.

The average weekly price growth across all stocks in the @Drugstore Chains industry was -8.12%. For the same industry, the average monthly price growth was +28.07%, and the average quarterly price growth was -33.62%.

Reported Earning Dates

LFMD is expected to report earnings on Mar 15, 2027.

PETS is expected to report earnings on Feb 10, 2027.

Industries' Descriptions

@Services to the Health Industry (-1.19% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

@Drugstore Chains (-8.12% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

LFMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFMD has been loosely correlated with PAYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LFMD jumps, then PAYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFMD
1D Price
Change %
LFMD100%
+32.63%
PAYS - LFMD
41%
Loosely correlated
+0.32%
AFRM - LFMD
39%
Loosely correlated
-1.11%
DAVE - LFMD
38%
Loosely correlated
+3.62%
TDOC - LFMD
37%
Loosely correlated
+1.27%
VERX - LFMD
37%
Loosely correlated
+1.27%
More

PETS and

Correlation & Price change

A.I.dvisor tells us that PETS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETS
1D Price
Change %
PETS100%
-4.96%
LFMD - PETS
22%
Poorly correlated
+32.63%
HITI - PETS
22%
Poorly correlated
-1.20%
YI - PETS
19%
Poorly correlated
+3.70%
SCNX - PETS
6%
Poorly correlated
-3.65%
LFMDP - PETS
5%
Poorly correlated
+8.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CEPI28.60N/A
N/A
Rex Crypto Equity Premium Income ETF
FCXG14.48N/A
N/A
Leverage Shares 2x Long FCX Daily ETF (FCXG)
TY33.93-0.16
-0.47%
TRI-Continental Corp
COIW5.21-0.16
-2.98%
Roundhill COIN WeeklyPay ETF (COIW)
AMDY42.28-3.96
-8.56%
YieldMax AMD Option Income Strategy ETF